Amino acids as cryoprotectants for liposomal delivery systems

被引:52
|
作者
Mohammed, Afzal R.
Coombes, Allan G. A.
Perrie, Yvonne
机构
[1] Aston Univ, Aston Pharm Sch, Med Res Unit, Birmingham B4 7ET, W Midlands, England
[2] Kingston Univ, Sch Pharm & Chem, Surrey, England
关键词
liposomes; amino acids; cryoprotectants; freeze drying; environmental scanning electron; microscopy; stability;
D O I
10.1016/j.ejps.2007.01.001
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Liposomes provide an efficient delivery system for solubilisation. and delivery of both small and macro molecules. However, they suffer from the disadvantage of instability when stored as aqueous dispersions. Cryoprotection of the liposomal systems provides an effective approach to overcome poor stability whilst maintaining formulation characteristics, although, the formulation of a freeze-dried product requires the consideration of not only the selection of an appropriate cryoprotectant, but also needs careful consideration of the processing parameters including pre-freezing conditions, primary and secondary drying protocols along with optimisation of cryoprotectant concentration. This current work investigates the application of amino acids as potential cryoprotectants for the stabilisation of liposomes, and results indicate that amino acids show biphasic nature of stabilisation with 4 mol of cryoprotectant per mole of the lipid exhibiting optimum cryoprotection. The investigations of process parameters showed that the pre-freezing temperatures below the glass transition of the amino acids followed by drying for over 6 h resulted in stable formulations. Studies investigating the efficiency of drug retention showed that the cryoprotection offered by lysine was similar to that shown by trehalose, suggesting that amino acids act as effective stabilisers. ESEM analysis was carried out to monitor morphology of the rehydrated liposomes. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:406 / 413
页数:8
相关论文
共 50 条
  • [21] Photochemically activated liposomal platform for enhanced nuclei acids delivery
    Chen, W.
    Deng, W.
    Zhao, X.
    Vo, J. N.
    Goldys, E. M.
    Cui, H.
    HUMAN GENE THERAPY, 2017, 28 (12) : A122 - A123
  • [22] Design of liposomal colloidal systems for ocular delivery of ciprofloxacin
    Taha, Ehab I.
    El-Anazi, Magda H.
    El-Bagory, Ibrahim M.
    Bayomi, Mohsen A.
    SAUDI PHARMACEUTICAL JOURNAL, 2014, 22 (03) : 231 - 239
  • [23] The potential of pectin as a stabilizer for liposomal drug delivery systems
    Smistad, Gro
    Boyum, Silje
    Alund, Siv Jorunn
    Samuelsen, Anne Bent C.
    Hiorth, Marianne
    CARBOHYDRATE POLYMERS, 2012, 90 (03) : 1337 - 1344
  • [24] Liposomal delivery systems for intestinal lymphatic drug transport
    Ahn H.
    Park J.-H.
    Biomaterials Research, 20 (1)
  • [25] STUDY OF THE SEDIMENTATION BEHAVIOR OF LIPOSOMAL DRUG DELIVERY SYSTEMS
    VARGHABUTLER, FI
    FOLDVARI, M
    MEZEI, M
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1988, 195 : 177 - COLL
  • [26] RECENT ADVANCES IN LIPOSOMAL DRUG-DELIVERY SYSTEMS
    CHONN, A
    CULLIS, PR
    CURRENT OPINION IN BIOTECHNOLOGY, 1995, 6 (06) : 698 - 708
  • [27] Liposomal Delivery Systems: Design Optimization and Current Applications
    Abu Lila, Amr Selim
    Ishida, Tatsuhiro
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2017, 40 (01) : 1 - 10
  • [28] Delivery of Suramin as an Antiviral Agent through Liposomal Systems
    Mastrangelo, Eloise
    Mazzitelli, Stefania
    Fabbri, Jacopo
    Rohayem, Jacques
    Ruokolainen, Janne
    Nykanen, Antti
    Milani, Mario
    Pezzullo, Margherita
    Nastruzzi, Claudio
    Bolognesi, Martino
    CHEMMEDCHEM, 2014, 9 (05) : 933 - 939
  • [29] Formulation and advantages of furazolidone in liposomal drug delivery systems
    Alam, Muhammad Irfan
    Paget, Timothy
    Elkordy, Amal Ali
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 84 : 139 - 145
  • [30] Mucoadhesive liposomal delivery systems: the choice of coating material
    Karn, Pankaj Ranjan
    Vanic, Zeljka
    Pepic, Ivan
    Skalko-Basnet, Natasa
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2011, 37 (04) : 482 - 488